Grace Capital’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.41M | Buy |
84,250
+1,900
| +2% | +$31.7K | 0.83% | 33 |
|
|
2021
Q3 | $3.99M | Buy |
82,350
+5,000
| +6% | +$242K | 2.45% | 7 |
|
|
2021
Q2 | $4.72M | Buy |
77,350
+450
| +0.6% | +$27.4K | 3.16% | 6 |
|
|
2021
Q1 | $4.74M | Hold |
76,900
| – | – | 3.01% | 6 |
|
|
2020
Q4 | $5.47M | Buy |
76,900
+3,475
| +5% | +$247K | 3.45% | 4 |
|
|
2020
Q3 | $2.75M | Sell |
73,425
-1,000
| -1% | -$37.5K | 2.14% | 10 |
|
|
2020
Q2 | $2.43M | Buy |
74,425
+39,925
| +116% | +$1.3M | 2.08% | 6 |
|
|
2020
Q1 | $1M | Hold |
34,500
| – | – | 0.98% | 27 |
|
|
2019
Q4 | $1.21M | Buy |
34,500
+11,000
| +47% | +$385K | 0.99% | 23 |
|
|
2019
Q3 | $504K | Buy |
+23,500
| New | +$504K | 0.51% | 60 |
|